Recombinant human c-Mpl ligand is not a direct stimulator of proplatelet formation in mature human megakaryocytes

Br J Haematol. 1996 Aug;94(2):387-90. doi: 10.1046/j.1365-2141.1996.d01-1813.x.

Abstract

To evaluate the effect of the c-Mpl ligand on platelet production by megakaryocytes, we investigated proplatelet formation in isolated human megakaryocytes cultured in serum-free medium, with or without the c-Mpl ligand, interleukin-6 and erythropoietin. When interleukin-6 was added to the culture medium, the percentage of megakaryocytes displaying proplatelets was approximately 1.5-fold the control value; whereas, in the presence of the c-Mpl ligand, the percentage of megakaryocytes displaying proplatelets decreased in a dose-dependent manner and did not increase compared to control values at any dose tested. However, the viability of megakaryocytes after a 4 d culture in the presence of the c-Mpl ligand was significantly higher than that of the cells cultured without it. The c-Mpl ligand did not stimulate the proplatelet formation in megakaryocytes in vitro.

MeSH terms

  • Blood Platelets / drug effects*
  • Cells, Cultured
  • Culture Media, Serum-Free
  • Humans
  • Interleukin-6 / pharmacology
  • Megakaryocytes / drug effects*
  • Recombinant Proteins / pharmacology
  • Thrombopoietin / pharmacology*

Substances

  • Culture Media, Serum-Free
  • Interleukin-6
  • Recombinant Proteins
  • Thrombopoietin